You are viewing the site in preview mode

Skip to main content

Table 1 Patients and controls characteristics

From: T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study

Clinical characteristic COVID-19 (n = 27) Control (n = 27) p
Age, mean, years (SD) 54 (12) 58 (12) 0.263
Gender male, No. (%) 19 (70.4) 23 (85.2) 0.129
CVD comorbidities, No. (%)
 Hypertension 8 (29.6) 9 (33.3) 0.770
 CAD 0 0 1
 Diabetes type II 2 (7.4) 3 (11.1) 0.639
 Dyslipidemia 2 (7.4) 2 (7.4) 1
Smoking 3 (11.1) 2 (7.4) 0.639
  1. CAD coronary artery disease, COVID-19 Coronavirus disease 19, CVD cardiovascular disease, SD standard deviation